These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4339184)

  • 61. Identity of HeLa cell determinants acquired by vesicular stomatitis virus with a tumor antigen.
    Little LM; Zavada J; Der CJ; Huang AS
    Science; 1983 Jun; 220(4601):1069-71. PubMed ID: 6302845
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The organization of the proteins of vesicular stomatitis virions: labeling with pyridoxal phosphate.
    Eger R; Compans RW; Rifkin DB
    Virology; 1975 Aug; 66(2):610-5. PubMed ID: 168689
    [No Abstract]   [Full Text] [Related]  

  • 63. Model for vesicular stomatitis virus.
    Cartwright B; Smale CJ; Brown F; Hull R
    J Virol; 1972 Aug; 10(2):256-60. PubMed ID: 4342242
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Induction of avian tumor viruses in normal cells by physical and chemical carcinogens.
    Weiss RA; Friis RR; Katz E; Vogt PK
    Virology; 1971 Dec; 46(3):920-38. PubMed ID: 4332981
    [No Abstract]   [Full Text] [Related]  

  • 65. Concentration and purification of vesicular stomatitis virus by polyethylene glycol "precipitation".
    McSharry J; Benzinger R
    Virology; 1970 Mar; 40(3):745-6. PubMed ID: 4314510
    [No Abstract]   [Full Text] [Related]  

  • 66. Effect of polyionic compounds on the plating efficiency of some strains of vesicular stomatitis virus.
    Gomes I; Vieira A
    Arch Gesamte Virusforsch; 1971; 34(3):223-31. PubMed ID: 4330136
    [No Abstract]   [Full Text] [Related]  

  • 67. Pseudotype formation between enveloped RNA and DNA viruses.
    Huang AS; Palma EL; Hewlett N; Roizman B
    Nature; 1974 Dec; 252(5485):743-5. PubMed ID: 4373658
    [No Abstract]   [Full Text] [Related]  

  • 68. Experimental vesicular stomatitis virus infection: ultrastructural pathology.
    Murphy FA; Harrison AK; Bauer SP
    Exp Mol Pathol; 1975 Dec; 23(3):426-40. PubMed ID: 172368
    [No Abstract]   [Full Text] [Related]  

  • 69. Correlation of polypeptide composition with antigenic variation in the swine vesicular disease and coxsackie B5 viruses.
    Harris TJ; Brown F
    Nature; 1975 Dec; 258(5537):758-60. PubMed ID: 174002
    [No Abstract]   [Full Text] [Related]  

  • 70. Immunochemical analysis of Mycoplasma pneumoniae. 3. Separation and chemical identification of serologically active lipids.
    Plackett P; Marmion BP; Shaw EJ; Lemcke RM
    Aust J Exp Biol Med Sci; 1969 Apr; 47(2):171-95. PubMed ID: 5795461
    [No Abstract]   [Full Text] [Related]  

  • 71. Rapid complement fixation technique for estimating complement-fixing antigen elution profiles of viruses from gel filtration columns.
    Cornesky RA; Hammon WM; Sather GE; Atchison R
    Appl Microbiol; 1972 Jul; 24(1):157-9. PubMed ID: 5057370
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The relationship between soluble antigens and the virion of adenovirus type 3. 3. Immunological identification of fiber antigen and isolated vertex capsomer antigen.
    Norrby E; Skaaret P
    Virology; 1967 Jul; 32(3):489-502. PubMed ID: 4961617
    [No Abstract]   [Full Text] [Related]  

  • 73. Immunochemical characterization of plaque mutants of simian virus 40.
    Ozer HL; Takemoto KK; Kirschstein RL; Axelrod D
    J Virol; 1969 Jan; 3(1):17-24. PubMed ID: 4306300
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Toward development of assays for scrapie-specific antibodies.
    Kasper KC; Bowman K; Stites DP; Prusiner SB
    Adv Exp Med Biol; 1981; 134():401-13. PubMed ID: 6261543
    [No Abstract]   [Full Text] [Related]  

  • 75. The antigens of varicella-zoster virus.
    Brunell PA; Granat M; Gershon AA
    J Immunol; 1972 Mar; 108(3):731-7. PubMed ID: 4334881
    [No Abstract]   [Full Text] [Related]  

  • 76. Soluble antigens of vaccinia-infected mammalian cells. I. Separation of virus-induced soluble antigens into two classes on the basis of physical characteristics.
    Cohen GH; Wilcox WC
    J Bacteriol; 1966 Sep; 92(3):676-86. PubMed ID: 5922541
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Physical, chemical and biological properties of a specific toxic lipid-protein complex formed in thermally altered mouse skin.
    Schoenenberger GA; Bauer U; Cueni L; Eppenberger U; Städtler K; Allgöwer M
    Biochim Biophys Acta; 1972 Mar; 263(1):164-77. PubMed ID: 5013288
    [No Abstract]   [Full Text] [Related]  

  • 78. In situ antigen localization with fluorescamine-conjugated antibodies: a new method.
    Sung MT; Bozzola JJ; Richards JC
    Anal Biochem; 1978 Jan; 84(1):225-30. PubMed ID: 204213
    [No Abstract]   [Full Text] [Related]  

  • 79. Neuropathological and immunofluorescence studies of experimental vesicular stomatitis virus encephalitis in mice.
    Miyoshi K; Harter DH; Hsu KC
    J Neuropathol Exp Neurol; 1971 Apr; 30(2):266-77. PubMed ID: 4336813
    [No Abstract]   [Full Text] [Related]  

  • 80. Large glucagon immunoreactivity in extracts of pancreas.
    Rigopoulou D; Valverde I; Marco J; Faloona G; Unger RH
    J Biol Chem; 1970 Feb; 245(3):496-501. PubMed ID: 5412706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.